Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:31 pm Purchase | 2025-02-07 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 4,125,000 5.440% | 1,125,000 (+37.50%) | Filing History |
| 2025-02-14 4:05 pm Purchase | 2025-02-07 | 13G | Nurix Therapeutics, Inc. NRIX | COMMODORE CAPITAL LP | 3,850,000 5.100% | 3,850,000 (New Position) | Filing History |
| 2025-02-14 08:42 am Purchase | 2024-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 3,000,000 4.240% | 2,170 (+0.07%) | Filing History |
| 2025-01-10 9:33 pm Sale | 2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX | ARK Investment Management LLC | 0 0.000% | -3,194,999 (Position Closed) | Filing History |
| 2024-12-06 11:34 am Purchase | 2024-11-29 | 13G | Nurix Therapeutics, Inc. NRIX | FMR LLC | 10,306,351 14.500% | 10,306,351 (New Position) | Filing History |
| 2024-11-14 9:00 pm Purchase | 2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX | Redmile Group, LLC | 6,970,307 9.900% | 1,948,421 (+38.80%) | Filing History |
| 2024-11-14 4:21 pm Purchase | 2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX | Baker Bros. Advisors LP | 6,751,565 9.700% | 1,799,113 (+36.33%) | Filing History |
| 2024-11-14 4:08 pm Purchase | 2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX | SANDS ARTHUR T | 3,272,832 4.700% | 564,936 (+20.86%) | Filing History |
| 2024-11-14 12:48 pm Sale | 2024-11-14 | 13G | Nurix Therapeutics, Inc. NRIX | WASATCH ADVISORS LP | 708,377 1.100% | -2,041,368 (-74.24%) | Filing History |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX | WELLINGTON MANAGEMENT GROUP LLP | 3,482,105 5.410% | 2,319,789 (+199.58%) | Filing History |
| 2024-11-07 5:37 pm Sale | 2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX | MORGAN STANLEY MS | 1,758,053 2.700% | -1,341,145 (-43.27%) | Filing History |
| 2024-06-07 1:30 pm Purchase | 2024-05-31 | 13G | Nurix Therapeutics, Inc. NRIX | BlackRock Inc. BLK | 6,042,150 10.200% | 1,398,414 (+30.11%) | Filing History |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Redmile Group, LLC | 5,021,886 9.900% | 122,114 (+2.49%) | Filing History |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Baker Bros. Advisors LP | 4,952,452 9.990% | 150,498 (+3.13%) | Filing History |
| 2024-02-14 10:03 am Sale | 2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | T. Rowe Price Associates, Inc. | 2,391,866 4.900% | -861,870 (-26.49%) | Filing History |
| 2024-02-14 08:51 am Purchase | 2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 2,997,830 6.180% | 280,659 (+10.33%) | Filing History |
| 2024-02-14 08:00 am Purchase | 2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | SANDS ARTHUR T | 2,707,896 5.400% | 2,707,896 (New Position) | Filing History |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | Nurix Therapeutics, Inc. NRIX | VANGUARD GROUP INC | 2,598,097 5.360% | 2,598,097 (New Position) | Filing History |
| 2024-02-09 1:56 pm Purchase | 2024-02-09 | 13G | Nurix Therapeutics, Inc. NRIX | WASATCH ADVISORS LP | 2,749,745 5.700% | 211,113 (+8.32%) | Filing History |
| 2024-02-09 1:47 pm Purchase | 2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | MORGAN STANLEY MS | 3,099,198 6.400% | 3,099,198 (New Position) | Filing History |